| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.16 | 0.0004 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.001 |